RSBN1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.641010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.278800E-01
Normal-vs-Stage2
1.684580E-01
Normal-vs-Stage3
2.792000E-01
Normal-vs-Stage4
7.574200E-01
Stage1-vs-Stage2
2.471800E-01
Stage1-vs-Stage3
5.922400E-02
Stage1-vs-Stage4
9.579400E-01
Stage2-vs-Stage3
1.507410E-01
Stage2-vs-Stage4
3.844800E-01
Stage3-vs-Stage4
1.247990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.594430E-01
Normal-vs-AfricanAmerican
6.312800E-01
Normal-vs-Asian
2.597400E-01
Caucasian-vs-AfricanAmerican
4.101200E-01
Caucasian-vs-Asian
4.683000E-01
AfricanAmerican-vs-Asian
3.735400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.752830E-01
Normal-vs-Female
1.817020E-01
Male-vs-Female
9.592800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.406600E-01
Normal-vs-Age(41-60Yrs)
4.231800E-01
Normal-vs-Age(61-80Yrs)
1.014400E-01
Normal-vs-Age(81-100Yrs)
1.792590E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.289200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.593200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.379800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.959300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.276630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.182760E-01
Normal-vs-Daily Drinker
7.600300E-02
Normal-vs-Weekly Drinker
2.218600E-01
Normal-vs-Occasional Drinker
3.791200E-01
Normal-vs-Social Drinker
4.338400E-01
Non Drinker-vs-Daily Drinker
6.374000E-01
Non Drinker-vs-Weekly Drinker
5.983600E-01
Non Drinker-vs-Occasional Drinker
1.445760E-01
Non Drinker-vs-Social Drinker
1.825420E-01
Daily Drinker-vs-Weekly Drinker
8.686200E-01
Daily Drinker-vs-Occasional Drinker
6.350500E-02
Daily Drinker-vs-Social Drinker
9.095800E-02
Weekly Drinker-vs-Occasional Drinker
1.500960E-01
Weekly Drinker-vs-Social Drinker
1.904620E-01
Occasional Drinker-vs-Social Drinker
9.933800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.554500E-02
Normal-vs-Grade 2
7.301800E-03
Normal-vs-Grade 3
1.458240E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.169800E-01
Grade 1-vs-Grade 3
1.670400E-01
Grade 1-vs-Grade 4
3.554500E-02
Grade 2-vs-Grade 3
1.478580E-01
Grade 2-vs-Grade 4
7.301800E-03
Grade 3-vs-Grade 4
1.458240E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.494800E-01
Normal-vs-NonDiabetic
1.069810E-01
Diabetic-vs-NonDiabetic
6.957000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.515800E-01
Normal-vs-NoPancreatitis
1.250200E-01
Pancreatitis-vs-NoPancreatitis
7.988400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.829360E-01
Normal-vs-N1
1.675170E-01
N0-vs-N1
8.616200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.560400E-01
Normal-vs-TP53-NonMutant
5.878800E-01
TP53-Mutant-vs-TP53-NonMutant
3.793800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
